FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Light Chain Amyloidosis
Interventions
DRUG

FKC288

Administration of FKC288 Four dose groups of 0.1×10\^6 CAR-T/kg, 0.3×10\^6 CAR-T/kg, 1.0×10\^6 CAR-T/kg, and 3.0×10\^6 CAR-T/kg FKC288 are designed in this study. 3 to 6 subjects are expected to be enrolled in each dose group according to observed DLT.

Trial Locations (1)

210016

RECRUITING

Jinling Hospital, Nanjing

All Listed Sponsors
lead

Nanjing University School of Medicine

OTHER